|
Monday 13th June 2022 |
Text too small? |
Comvita now forecasts that its full year reported EBITDA is expected to be in a range of $28.5M –$30.0M (previous guidance operating EBITDA $27M – $30M). For clarity, this new range includes Comvita absorbing the impact of previously disclosed one off M&A costs of circa $1M. Comvita is also forecasting double digit growth in Net Profit after Tax for the full year versus the prior corresponding period.
Commenting David Banfield “I am delighted with the momentum that we are experiencing in the business and the ongoing resilience of our focused business model. Consumers continue to choose premium solutions from Comvita as a key part of helping to build natural immunity. This updated guidance is particularly encouraging given the material disruption to offline trade in mainland China through the last quarter and is testament to the quality of our team around the world and at home in Aotearoa, New Zealand”.
Ends.
Comvita full year guidance update – FY22
No comments yet
AFT delivers 10th consecutive first half revenue increase
Steel & Tube - Trading Update - November 2025
November 20th Morning Report
NPH - 2025 Full Year Results
RAD - Radius Care Triples 1H26 NPAT
APL - Result for the six months ended 30 September 2025
November 19th Morning Report
Devon Funds Morning Note - 18 November 2025
Sanford delivers a record full year result
November 18th Morning Report